BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34170455)

  • 1. Outcomes of haploidentical bone marrow transplantation in patients with severe aplastic anemia-II that progressed from non-severe acquired aplastic anemia.
    Liu H; Zheng X; Zhang C; Xie J; Gao B; Shao J; Yang Y; Wang H; Yan J
    Front Med; 2021 Oct; 15(5):718-727. PubMed ID: 34170455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia].
    Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients.
    Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Mao N; Guo ZK; Ning HM; Wang HX; Zhu H
    Stem Cells Transl Med; 2021 Feb; 10(2):291-302. PubMed ID: 32978903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
    Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
    Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
    Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
    Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
    Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 76 patients with severe aplastic anemia treated with haploid hematopoietic stem cell transplantation].
    Zhang Y; Zhang GX; Pang AM; Yang DL; Zhang RL; Zhai WH; Wei JL; He Y; Jiang EL; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):202-210. PubMed ID: 37356981
    [No Abstract]   [Full Text] [Related]  

  • 9. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide.
    DeZern AE; Zahurak ML; Symons HJ; Cooke KR; Rosner GL; Gladstone DE; Huff CA; Swinnen LJ; Imus P; Borrello I; Wagner-Johnston N; Ambinder RF; Luznik L; Bolaños-Meade J; Fuchs EJ; Jones RJ; Brodsky RA
    Blood Adv; 2020 Apr; 4(8):1770-1779. PubMed ID: 32343796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
    Arcuri LJ; Nabhan SK; Cunha R; Nichele S; Ribeiro AAF; Fernandes JF; Daudt LE; Rodrigues ALM; Arrais-Rodrigues C; Seber A; Atta EH; de Oliveira JSR; Funke VAM; Loth G; Junior LGD; Paz A; Calixto RF; Gomes AA; Araujo CES; Colturato V; Simoes BP; Hamerschlak N; Flowers ME; Pasquini R; Rocha V; Bonfim C
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2311-2317. PubMed ID: 32949751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients.
    Ma X; Xu Z; Han T; Zhang Y; Han W; Fu H; Zhang X; Lin F; Huang X; Xu L
    Front Immunol; 2023; 14():1173320. PubMed ID: 37234156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia].
    Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835
    [No Abstract]   [Full Text] [Related]  

  • 14. Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia.
    DeZern AE; Brodsky RA
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):629-642. PubMed ID: 30047416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects.
    Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Guo ZK; Mao N; Ning HM; Wang HX; Heng Zhu
    Cytotherapy; 2022 Feb; 24(2):205-212. PubMed ID: 34799271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
    Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
    Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical study of haploidentical hematopoietic stem cell transplantation in the treatment of pediatric patients with acquired severe aplastic anemia: single center experience].
    Tang XF; Jing YF; Lu W; Huang YZ; Wu NH; Luan Z
    Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):301-305. PubMed ID: 31104441
    [No Abstract]   [Full Text] [Related]  

  • 18. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.
    Xu LP; Wang SQ; Wu DP; Wang JM; Gao SJ; Jiang M; Wang CB; Zhang X; Liu QF; Xia LH; Wang X; Huang XJ
    Br J Haematol; 2016 Oct; 175(2):265-274. PubMed ID: 27352174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Haploidentical Stem Cell Transplantation using Total Body Irradiation (600 cGy) and Fludarabine with Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia: A Prospective Phase II Study.
    Lee SE; Min GJ; Park SS; Park S; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Lee JW
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1906-1914. PubMed ID: 32634577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia-Single-Centre Experience.
    Stavi V; Khaire N; Lipton JH; Kumar R
    Curr Oncol; 2024 Feb; 31(3):1246-1252. PubMed ID: 38534926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.